Your browser doesn't support javascript.
loading
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.
Morschhauser, Franck; Tilly, Hervé; Chaidos, Aristeidis; McKay, Pamela; Phillips, Tycel; Assouline, Sarit; Batlevi, Connie Lee; Campbell, Phillip; Ribrag, Vincent; Damaj, Gandhi Laurent; Dickinson, Michael; Jurczak, Wojciech; Kazmierczak, Maciej; Opat, Stephen; Radford, John; Schmitt, Anna; Yang, Jay; Whalen, Jennifer; Agarwal, Shefali; Adib, Deyaa; Salles, Gilles.
Afiliación
  • Morschhauser F; Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU de Lille, Université de Lille, Lille, France. Electronic address: franck.morschhauser@chru-lille.fr.
  • Tilly H; Department of Hematology and INSERM U1245, Centre Henri Becquerel and Rouen University, Rouen, France.
  • Chaidos A; Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, Hammersmith Hospital & Imperial College Healthcare NHS Trust, London, UK.
  • McKay P; Department of Hematology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Phillips T; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Assouline S; Division of Hematology, Jewish General Hospital, Montreal, QC, Canada; Department of Oncology, McGill University, Montreal, QC, Canada.
  • Batlevi CL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Campbell P; Department of Clinical Haematology, Barwon Health, University Hospital Geelong, Geelong, VIC, Australia.
  • Ribrag V; Hematology Department, Gustave Roussy, Villejuif, France.
  • Damaj GL; Hematology Institute, Hematologie Clinique, University Hospital School of Medicine, Caen, France.
  • Dickinson M; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Jurczak W; Department of Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland.
  • Kazmierczak M; Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
  • Opat S; Haematology Department, Monash University, Melbourne, VIC, Australia.
  • Radford J; Department of Medical Oncology, University of Manchester, Manchester, UK; NIHR Manchester Clinical Research Facility, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK.
  • Schmitt A; Department of Hematology, Institut Bergonié, Bordeaux, France.
  • Yang J; Clinical Development, Epizyme, Cambridge, MA, USA.
  • Whalen J; Clinical Development, Epizyme, Cambridge, MA, USA.
  • Agarwal S; Clinical Development, Epizyme, Cambridge, MA, USA.
  • Adib D; Clinical Development, Epizyme, Cambridge, MA, USA.
  • Salles G; Department of Hematology, Lyon-Sud Hospital, University of Lyon, Pierre-Bénite, France.
Lancet Oncol ; 21(11): 1433-1442, 2020 11.
Article en En | MEDLINE | ID: mdl-33035457
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridonas / Benzamidas / Linfoma Folicular / Anticuerpos Monoclonales Humanizados / Proteína Potenciadora del Homólogo Zeste 2 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridonas / Benzamidas / Linfoma Folicular / Anticuerpos Monoclonales Humanizados / Proteína Potenciadora del Homólogo Zeste 2 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article